Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06032546 |
|---|---|
| Brief Title: | A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 |
| First Submitted : | September 5, 2023 |
| First Submitted that Met QC Criteria : | September 5, 2023 |
| First Posted : | September 13, 2023 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 (Estimate) |